» Articles » PMID: 28042326

Exosomes Derived from MiR-140-5p-overexpressing Human Synovial Mesenchymal Stem Cells Enhance Cartilage Tissue Regeneration and Prevent Osteoarthritis of the Knee in a Rat Model

Overview
Journal Theranostics
Date 2017 Jan 3
PMID 28042326
Citations 359
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Osteoarthritis (OA) is the most common joint disease throughout the world. Exosomes derived from miR-140-5p-overexpressing synovial mesenchymal stem cells (SMSC-140s) may be effective in treating OA. We hypothesized that exosomes derived from SMSC-140 (SMSC-140-Exos) would enhance the proliferation and migration abilities of articular chondrocytes (ACs) without harming extracellular matrix (ECM) secretion.

Methods: SMSCs were transfected with or without miR-140-5p. Exosomes derived from SMSCs or SMSC-140s (SMSC-Exos or SMSC-140-Exos) were isolated and identified. Proliferation, migration and ECM secretion were measured in vitro and compared between groups. The mechanism involving alternative Wnt signalling and activation of Yes-associated protein (YAP) was investigated using lentivirus, oligonucleotides or chemical drugs. The preventative effect of exosomes in vivo was measured using Safranin-O and Fast green staining and immunohistochemical staining.

Results: Wnt5a and Wnt5b carried by exosomes activated YAP via the alternative Wnt signalling pathway and enhanced proliferation and migration of chondrocytes with the side-effect of significantly decreasing ECM secretion. Highly-expressed miR-140-5p blocked this side-effect via RalA. SMSC-140-Exos enhanced the proliferation and migration of ACs without damaging ECM secretion in vitro, while in vivo, SMSC-140-Exos successfully prevented OA in a rat model.

Conclusions: These findings highlight the promising potential of SMSC-140-Exos in preventing OA. We first found a potential source of exosomes and studied their merits and shortcomings. Based on our understanding of the molecular mechanism, we overcame the shortcomings by modifying the exosomes. Such exosomes derived from modified cells hold potential as future therapeutic strategies.

Citing Articles

Extracecellulr vesicles (EVs) microRNAs (miRNAs) derived from mesenchymal stem cells (MSCs) in osteoarthritis (OA); detailed role in pathogenesis and possible therapeutics.

Pakdaman Kolour S, Nematollahi S, Dehbozorgi M, Fattahi F, Movahed F, Esfandiari N Heliyon. 2025; 11(3):e42258.

PMID: 40007782 PMC: 11850152. DOI: 10.1016/j.heliyon.2025.e42258.


The role of natural exosomes from SHED-MSC in immunoregulation of M0/M1 polarized macrophage cells.

Fallah A, Hosseinzadeh Colagar A, Khosravi A, Mohammad-Hasani A, Saeidi M Front Immunol. 2025; 16:1550280.

PMID: 39991155 PMC: 11842380. DOI: 10.3389/fimmu.2025.1550280.


Extracellular vesicle-mediated gene therapy targets BRAF-mutant colorectal cancer by inhibiting the MEK1/2-ERK1/2 pathway.

Wang D, Wang L, Zhang W, Xu K, Chen L, Guo Z J Nanobiotechnology. 2025; 23(1):129.

PMID: 39979881 PMC: 11843959. DOI: 10.1186/s12951-025-03205-4.


Engineered Extracellular Vesicles as a New Class of Nanomedicine.

Wen X, Hao Z, Yin H, Min J, Wang X, Sun S Chem Bio Eng. 2025; 2(1):3-22.

PMID: 39975802 PMC: 11835263. DOI: 10.1021/cbe.4c00122.


Strontium-Alix interaction enhances exosomal miRNA selectively loading in synovial MSCs for temporomandibular joint osteoarthritis treatment.

Yuan W, Liu J, Zhang Z, Ye C, Zhou X, Yi Y Int J Oral Sci. 2025; 17(1):6.

PMID: 39890774 PMC: 11785994. DOI: 10.1038/s41368-024-00329-5.


References
1.
Yimlamai D, Christodoulou C, Galli G, Yanger K, Pepe-Mooney B, Gurung B . Hippo pathway activity influences liver cell fate. Cell. 2014; 157(6):1324-1338. PMC: 4136468. DOI: 10.1016/j.cell.2014.03.060. View

2.
Prasadam I, Zhou Y, Shi W, Crawford R, Xiao Y . Role of dentin matrix protein 1 in cartilage redifferentiation and osteoarthritis. Rheumatology (Oxford). 2014; 53(12):2280-7. DOI: 10.1093/rheumatology/keu262. View

3.
Lee W, Yu S, Cheong S, Sonn J, Kim S . Ectopic expression of cyclooxygenase-2-induced dedifferentiation in articular chondrocytes. Exp Mol Med. 2009; 40(6):721-7. PMC: 2679341. DOI: 10.3858/emm.2008.40.6.721. View

4.
Pritzker K, Gay S, Jimenez S, Ostergaard K, Pelletier J, Revell P . Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage. 2005; 14(1):13-29. DOI: 10.1016/j.joca.2005.07.014. View

5.
Tao S, Gao Y, Zhu H, Yin J, Chen Y, Zhang Y . Decreased extracellular pH inhibits osteogenesis through proton-sensing GPR4-mediated suppression of yes-associated protein. Sci Rep. 2016; 6:26835. PMC: 4891712. DOI: 10.1038/srep26835. View